Apotex And Amarin Settle On Vascepa
US Market Entry Date Of 2029 Matches Teva Settlement
Apotex has settled patent litigation over Vascepa with Amarin, providing the generics firm with a guaranteed launch date in 2029.
Apotex has settled patent litigation over Vascepa with Amarin, providing the generics firm with a guaranteed launch date in 2029.